 management.33-35
NASCET and ECST both demonstrated the beneﬁt of
CEA compared with maximal medical treatment for
neurologically symptomatic patients with carotid stenosis with a reduced diameter of >50%.6,33-35 NASCET
demonstrated a relative risk (RR) reduction of 65% and
an absolute risk reduction in stroke of 17% at 2 years
(